Found: 31
Select item for more details and to access through your institution.
Safety, Tolerability and efficacy of Rapid Optimization, helped by NT-proBNP and GDF-15, of Heart Failure therapies (STRONG-HF): rationale and design for a multicentre, randomized, parallel-group study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
We told you so: 'knowledge is not enough to improve heart failure self-care behaviour'.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Futility in cardiology: the need for a change in perspectives.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Real-world versus trial patients with transthyretin amyloid cardiomyopathy.
- Published in:
- 2019
- By:
- Publication type:
- research
Predictors of thromboembolic events in Takotsubo syndrome.
- Published in:
- 2019
- By:
- Publication type:
- Letter
The changing face of cardiogenic shock complicating acute myocardial infarction.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Dapagliflozin in heart failure: new frontiers.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012-2015.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Decelerating trends in heart failure survival.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Futility in cardiology: the need for a change in perspectives: reply.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Heart Failure Association/European Society of Cardiology position paper on frailty in patients with heart failure.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Predictors of thromboembolic events in Takotsubo syndrome: reply.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Survival of patients with chronic heart failure in the community: a systematic review and meta-analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Haemoconcentration during treatment of acute heart failure with cardiorenal syndrome: from the CARRESS-HF trial.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Safety and efficacy of the partial adenosine A1 receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced ejection fraction: a phase IIb, randomized, double-blind, placebo-controlled trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Down the road from challenges in acute heart failure trials.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Temporal trends in incidence and patient characteristics in cardiogenic shock following acute myocardial infarction from 2010 to 2017: a Danish cohort study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Most elderly patients hospitalized for heart failure lack the abilities needed to perform the tasks required for self‐care: impact on outcomes.
- Published in:
- European Journal of Heart Failure, 2019, v. 21, n. 11, p. 1434, doi. 10.1002/ejhf.1559
- By:
- Publication type:
- Article
Prediction of short- and long-term mortality in takotsubo syndrome: the InterTAK Prognostic Score.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Immunosuppression in inflammatory cardiomyopathy and parvovirus B19 persistence.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Should providers prescribe sacubitril/valsartan based on trial eligibility, approval indication, or guideline recommendations?
- Published in:
- 2019
- By:
- Publication type:
- journal article
The Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure (DAPA-HF) trial: baseline characteristics.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Time to update our profiles.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Sex differences in cardiac function, biomarkers and exercise performance in heart failure with preserved ejection fraction: findings from the RELAX trial.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Sacubitril/valsartan eligibility and outcomes in the ESC‐EORP‐HFA Heart Failure Long‐Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM‐HF trial, ESC guidelines, and real world
- Published in:
- 2019
- By:
- Publication type:
- journal article
Biomarker guidance allows a more personalized allocation of patients for remote patient management in heart failure: results from the TIM-HF2 trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Acute heart failure congestion and perfusion status - impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical phenotypes of acute heart failure based on signs and symptoms of perfusion and congestion at emergency department presentation and their relationship with patient management and outcomes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
November 2019 at a glance. Chronic and acute heart failure: from epidemiology to treatment.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Issue Information.
- Published in:
- European Journal of Heart Failure, 2019, v. 21, n. 11, p. i, doi. 10.1002/ejhf.1275
- Publication type:
- Article